Elena G Nesukay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elena G Nesukay has a total of 142 co-authors. Here are the top co-authors by number of shared publications:
- S. V. Cherniuk
ДУ «Національний науковий центр “Інститут кардіології, клінічної та регенеративної медицини імені академіка М.Д. Стражеска” НАМН України», Київ
9 shared publications - R. M. Kirichenko
ДУ «Національний науковий центр “Інститут кардіології, клінічної та регенеративної медицини імені академіка М.Д. Стражеска” НАМН України», Київ
8 shared publications - V. M. Kovalenko
National Scientific Center «M.D. Strazhesko Institute of Cardiology, Clinical and Regenerative Medicine» of NAMS of Ukraine, Kyiv, Ukraine
7 shared publications - E. Yu. Titov
ДУ «Національний науковий центр “Інститут кардіології, клінічної та регенеративної медицини імені академіка М.Д. Стражеска” НАМН України», Київ
5 shared publications - A. B. Slyvna
ДУ «Національний науковий центр “Інститут кардіології, клінічної та регенеративної медицини імені академіка М.Д. Стражеска” НАМН України», Київ
4 shared publications - A. S. Kozliuk
SI “NSC “Strazhesko National Scientific Center of Cardiology and Regenerative Medicine of the NAMS of Ukraine
4 shared publications
Latest Publications
- Open Access
- 30 October 2026
- Published by Chetverta Khvylia in Ukrainian Journal of Cardiology
- Vol. 33 (5) , 73-82
Ремоделювання лівого передсердя і лівого шлуночка як предиктор персистенції аритмій при запальній та дилатаційній кардіоміопатії
Мета роботи – дослідити частоту і спектр порушень серцевого ритму та визначити предиктори їх персистенції на основі вивчення структурно-функціонального стану лівого передсердя (ЛП) та лівого шлуночка (ЛШ) у хворих із запальною і дилатаційною кардіоміопатією. Матеріали і методи. У дослідження залучено 55 хворих зі зниженою фракцією викиду (ФВ) ЛШ ≤ 40 % та серцевою недостатністю (СН) ІІ функціонального класу і більше: 1-шу групу становили 32 пацієнти із запальною кардіоміопатією (ЗКМП), до 2-ї групи увійшли 23 пацієнти з дилатаційною кардіоміопатією (ДКМП). Усім пацієнтам проводили добове моніторування ЕКГ з метою визначення частоти і спектра аритмій, ехокардіографію та спекл-трекінг ехокардіографію для оцінки структурно-функціонального стану ЛП та ЛШ, а також магнітно-резонансну томографію серця з відстроченим контрастуванням.Результати. Хворі із ЗКМП характеризувалися менш значущим порушенням структурно-функціонального стану ЛП порівняно з пацієнтами із ДКМП, при якій спостерігали збільшення індексу об’єму на 17,2 % та зменшення показника систолічної деформації ЛП на 23,4 %, а також збільшення об’єму його фібротичного ураження майже вдвічі згідно з результатами магнітно-резонансної томографії серця, що асоціювалося з частішими пароксизмами фібриляції передсердь. Також за результатами магнітно-резонансної томографії серця у пацієнтів із ЗКМП порівняно з пацієнтами із ДКМП виявляли зменшення на 13,1 % індексу кінцеводіастолічного об’єму та збільшення показників поздовжньої та циркулярної деформації ЛШ відповідно на 23,8 та 23,6 %, а також зменшення кількості уражених сегментів на 23,4 % та показника фракції позаклітинного об’єму ЛШ на 24,9 % . За допомогою багатофакторного регресійного аналізу у хворих як із ЗКМП, так і з ДКМП, було встановлено граничні значення показників структурно-функціонального стану серця, що були незалежними чинниками персистенції пароксизмів нестійкої шлуночкової тахікардії та фібриляції передсердь.Висновки. Хворі із ЗКМП характеризувалися менш тяжким порушенням структурно-функціонального стану ЛП та ЛШ порівняно з пацієнтами з ДКМП, що асоціювалося із меншою частотою виявлення порушень серцевого ритму. У хворих із запальною та дилатаційною кардіоміопатією встановлено незалежні чинники, асоційовані з наявністю фібриляції передсердь та пароксизмів нестійкої шлуночкової тахікардії.
- 30 October 2026
- Published by Chetverta Khvylia in Ukrainian Journal of Cardiology
- Vol. 33 (5) , 73-82
Open AccessРемоделювання лівого передсердя і лівого шлуночка як предиктор персистенції аритмій при запальній та дилатаційній кардіоміопатії
Мета роботи – дослідити частоту і спектр порушень серцевого ритму та визначити предиктори їх персистенції на основі вивчення структурно-функціонального стану лівого передсердя (ЛП) та лівого шлуночка (ЛШ) у хворих із запальною і дилатаційною кардіоміопатією. Матеріали і методи. У дослідження залучено 55 хворих зі зниженою фракцією викиду (ФВ) ЛШ ≤ 40 % та серцевою недостатністю (СН) ІІ функціонального класу і більше: 1-шу групу становили 32 пацієнти із запальною кардіоміопатією (ЗКМП), до 2-ї групи увійшли 23 пацієнти з дилатаційною кардіоміопатією (ДКМП). Усім пацієнтам проводили добове моніторування ЕКГ з метою визначення частоти і спектра аритмій, ехокардіографію та спекл-трекінг ехокардіографію для оцінки структурно-функціонального стану ЛП та ЛШ, а також магнітно-резонансну томографію серця з відстроченим контрастуванням.Результати. Хворі із ЗКМП характеризувалися менш значущим порушенням структурно-функціонального стану ЛП порівняно з пацієнтами із ДКМП, при якій спостерігали збільшення індексу об’єму на 17,2 % та зменшення показника систолічної деформації ЛП на 23,4 %, а також збільшення об’єму його фібротичного ураження майже вдвічі згідно з результатами магнітно-резонансної томографії серця, що асоціювалося з частішими пароксизмами фібриляції передсердь. Також за результатами магнітно-резонансної томографії серця у пацієнтів із ЗКМП порівняно з пацієнтами із ДКМП виявляли зменшення на 13,1 % індексу кінцеводіастолічного об’єму та збільшення показників поздовжньої та циркулярної деформації ЛШ відповідно на 23,8 та 23,6 %, а також зменшення кількості уражених сегментів на 23,4 % та показника фракції позаклітинного об’єму ЛШ на 24,9 % . За допомогою багатофакторного регресійного аналізу у хворих як із ЗКМП, так і з ДКМП, було встановлено граничні значення показників структурно-функціонального стану серця, що були незалежними чинниками персистенції пароксизмів нестійкої шлуночкової тахікардії та фібриляції передсердь.Висновки. Хворі із ЗКМП характеризувалися менш тяжким порушенням структурно-функціонального стану ЛП та ЛШ порівняно з пацієнтами з ДКМП, що асоціювалося із меншою частотою виявлення порушень серцевого ритму. У хворих із запальною та дилатаційною кардіоміопатією встановлено незалежні чинники, асоційовані з наявністю фібриляції передсердь та пароксизмів нестійкої шлуночкової тахікардії.
- Open Access
- 27 February 2026
- Published by Chetverta Khvylia in Ukrainian Journal of Cardiology
- Vol. 33 (1) , 37-49
Characteristics and prognostic assessment of acute myocarditis in patients under martial law in Ukraine: long-term follow-up results
The aim of the study – to investigate the course of myocarditis in patients, including combatants, with different risk profiles and to determine prognostic factors for an unfavorable outcome over 24 months of observation under martial law conditions. Material and methods. A total of 204 patients with AM (134 men and 70 women; mean age 38.2±8.6 years), including 90 combatants, were examined. Patients were stratified into three risk categories: the 1st group consisted of 80 high risk patients with de novo reduced LVEF (≤ 40 %), clinical signs of heart failure, and extensive LGE on cardiac MRI; the 2nd group comprised 64 intermediate risk patients with moderately reduced LVEF (41–49 %) and ≥ 2 affected LV segments on MRI; the 3rd group included 60 low risk patients with preserved LVEF (≥ 50 %) and < 2 affected LV segments. All patients underwent speckle-tracking echocardiography, 24-hour ECG monitoring with arrhythmia and HRV assessment, cardiac MRI with LGE. Comprehensive diagnostic assessments were performed within the AM onset and repeated at 12 and 24 months.Results and discussion. Predictors of persistent myocarditis over the 24-month follow-up were identified: baseline LV EDVi ≥ 105 mL/m², LVEF ≤ 40 %, GLS ≤ 9.0 %, GCS ≤ 8.0 %, presence of NSVT paroxysms, a total of ≥ 5 affected LV segments and ≥ 3 LV segments with inflammatory involvement. Predictors of transition to dilated cardiomyopathy included an LV EDVi ≥ 105 mL/m², LVEF < 30 %, GLS ≤ 8.0 %, GCS ≤ 7.0 %, a total of ≥ 9 affected LV segments, and ≥ 5 LGE-positive segments during baseline investigation. Predictors of recovery at 24 months were an LV EDVi ≤ 85 mL/m², LVEF ≥ 50 %, GLS ≥ 11.0 %, GCS ≥ 12.0 %, involvement of ≤ 3 LV segments, and absence of NSVT during the baseline assessment within the first month after symptom onset. Among combatants with myocarditis predictors of persistent frequent supraventricular ectopy and atrial fibrillation at 24 months included a HADS anxiety score ≥ 11, HAM-A score ≥ 25, LF/HF ratio ≤ 1.20, ≥ 5 affected LV segments, and ≥ 2 LV segments with LGE on baseline MRI. Additional predictors of persistent atrial fibrillation included an LV EDVi ≥ 105 mL/m² and LVEF ≤ 40 %.Conclusions. Results of the study refined contemporary approaches to prognosticating the clinical course of myocarditis and identified predictors of recovery, long-term disease persistence and transition to dilated cardiomyopathy. Among combatants with myocarditis predictors of persistent frequent supraventricular ectopy and atrial fibrillation paroxysms at 24 months were established, along with an association between these arrhythmias, the presence of anxiety and impaired heart rate variability.
- 27 February 2026
- Published by Chetverta Khvylia in Ukrainian Journal of Cardiology
- Vol. 33 (1) , 37-49
Open AccessCharacteristics and prognostic assessment of acute myocarditis in patients under martial law in Ukraine: long-term follow-up results
The aim of the study – to investigate the course of myocarditis in patients, including combatants, with different risk profiles and to determine prognostic factors for an unfavorable outcome over 24 months of observation under martial law conditions. Material and methods. A total of 204 patients with AM (134 men and 70 women; mean age 38.2±8.6 years), including 90 combatants, were examined. Patients were stratified into three risk categories: the 1st group consisted of 80 high risk patients with de novo reduced LVEF (≤ 40 %), clinical signs of heart failure, and extensive LGE on cardiac MRI; the 2nd group comprised 64 intermediate risk patients with moderately reduced LVEF (41–49 %) and ≥ 2 affected LV segments on MRI; the 3rd group included 60 low risk patients with preserved LVEF (≥ 50 %) and < 2 affected LV segments. All patients underwent speckle-tracking echocardiography, 24-hour ECG monitoring with arrhythmia and HRV assessment, cardiac MRI with LGE. Comprehensive diagnostic assessments were performed within the AM onset and repeated at 12 and 24 months.Results and discussion. Predictors of persistent myocarditis over the 24-month follow-up were identified: baseline LV EDVi ≥ 105 mL/m², LVEF ≤ 40 %, GLS ≤ 9.0 %, GCS ≤ 8.0 %, presence of NSVT paroxysms, a total of ≥ 5 affected LV segments and ≥ 3 LV segments with inflammatory involvement. Predictors of transition to dilated cardiomyopathy included an LV EDVi ≥ 105 mL/m², LVEF < 30 %, GLS ≤ 8.0 %, GCS ≤ 7.0 %, a total of ≥ 9 affected LV segments, and ≥ 5 LGE-positive segments during baseline investigation. Predictors of recovery at 24 months were an LV EDVi ≤ 85 mL/m², LVEF ≥ 50 %, GLS ≥ 11.0 %, GCS ≥ 12.0 %, involvement of ≤ 3 LV segments, and absence of NSVT during the baseline assessment within the first month after symptom onset. Among combatants with myocarditis predictors of persistent frequent supraventricular ectopy and atrial fibrillation at 24 months included a HADS anxiety score ≥ 11, HAM-A score ≥ 25, LF/HF ratio ≤ 1.20, ≥ 5 affected LV segments, and ≥ 2 LV segments with LGE on baseline MRI. Additional predictors of persistent atrial fibrillation included an LV EDVi ≥ 105 mL/m² and LVEF ≤ 40 %.Conclusions. Results of the study refined contemporary approaches to prognosticating the clinical course of myocarditis and identified predictors of recovery, long-term disease persistence and transition to dilated cardiomyopathy. Among combatants with myocarditis predictors of persistent frequent supraventricular ectopy and atrial fibrillation paroxysms at 24 months were established, along with an association between these arrhythmias, the presence of anxiety and impaired heart rate variability.
- Top Cited Papers
- 29 August 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (40) , 3952-4041
2025 ESC Guidelines for the management of myocarditis and pericarditis
- 29 August 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (40) , 3952-4041
Top Cited Papers2025 ESC Guidelines for the management of myocarditis and pericarditis
- Open Access
- 26 February 2025
- Published by Chetverta Khvylia in Ukrainian Journal of Cardiology
- Vol. 32 (1) , 29-35
Ефективність азатіоприну в лікуванні хворих із тяжким перебігом міокардиту: досвід одного центру
The aim – to evaluate the efficacy of combined immunosuppressive therapy with azathioprine and methylprednisolone in patients with severe myocarditis who did not improve left ventricular (LV) systolic function after 6 months of glucocorticoid (GC) therapy.Materials and methods. The study included 26 patients with chronic myocarditis, disease duration of more than 6 months and lack of efficacy of previous GC administration: functional class (FC) of HF remained at level II or higher, LV ejection fraction (EF) remained <40% at the time of inclusion in the study. All patients on the background of HF therapy according to modern standards were prescribed combined immunosuppressive therapy: azathioprine at a dose of 1 mg/kg of body weight for 6 months in combination with methylprednisolone at a dose of 0.25 mg/kg per day for 3 months with a gradual dose reduction of 1 mg per week until complete drug withdrawal 6 months after the start of treatment. Determination of the content of immunological biomarkers in the blood, cardiac magnetic resonance imaging (CMR) with intravenous contrast, transthoracic echocardiography and a 6-minute walk test were performed before the appointment of combined immunosuppressive therapy and after 6 months of treatment.Results. Before the appointment of combined immunosuppressive therapy, the average number of LV segments in which signs of inflammation were determined in the form of early contrast and/or T2 signal intensity enhancement was 7.25±0.36 segments, and the number of segments with fibrotic myocardial damage was 5.81±0.32 on average. After 6 months, inflammatory changes were detected only in 2.20±0.17 LV segments, while the volume of fibrotic LV damage did not significantly change compared to the initial examination. When analyzing echocardiography data after 6 months of observation, a significant decrease in the LV end-diastolic volume index by 15.6% (p<0.05) and an increase in LV EF by 16.7% (p<0.05) were found. Also, after 6 months of observation, a significant decrease in the content of systemic inflammation markers was detected: the level of ferritin decreased by 41.5% (p<0.01), C-reactive protein – by 34.2% (p<0.01), the content of interleukin-6 and tumor necrosis factor α decreased by 93.8% and 33.3%, respectively (p<0.01), and the content of troponin I decreased 3 times compared to the baseline level before the appointment of azathioprine. According to the results of the 6-minute test, before the appointment of azathioprine, patients with FC III HF predominated, only a third had FC II, and 20% – FC IV. After 6 months of treatment, more than half of the studied patients had FC II HF, every fourth – FC I, and FC IV was not diagnosed in any patient.Conclusions. In patients with severe myocarditis, combined immunosuppressive therapy with azathioprine and glucocorticoids for 6 months was accompanied by a decrease in dilatation and improving the contractility of the left ventricle, improving the functional class of heart failure, reducing the number of myocardial segments affected by inflammatory changes as well as reducing the content of systemic inflammation markers.
- 26 February 2025
- Published by Chetverta Khvylia in Ukrainian Journal of Cardiology
- Vol. 32 (1) , 29-35
Open AccessЕфективність азатіоприну в лікуванні хворих із тяжким перебігом міокардиту: досвід одного центру
The aim – to evaluate the efficacy of combined immunosuppressive therapy with azathioprine and methylprednisolone in patients with severe myocarditis who did not improve left ventricular (LV) systolic function after 6 months of glucocorticoid (GC) therapy.Materials and methods. The study included 26 patients with chronic myocarditis, disease duration of more than 6 months and lack of efficacy of previous GC administration: functional class (FC) of HF remained at level II or higher, LV ejection fraction (EF) remained <40% at the time of inclusion in the study. All patients on the background of HF therapy according to modern standards were prescribed combined immunosuppressive therapy: azathioprine at a dose of 1 mg/kg of body weight for 6 months in combination with methylprednisolone at a dose of 0.25 mg/kg per day for 3 months with a gradual dose reduction of 1 mg per week until complete drug withdrawal 6 months after the start of treatment. Determination of the content of immunological biomarkers in the blood, cardiac magnetic resonance imaging (CMR) with intravenous contrast, transthoracic echocardiography and a 6-minute walk test were performed before the appointment of combined immunosuppressive therapy and after 6 months of treatment.Results. Before the appointment of combined immunosuppressive therapy, the average number of LV segments in which signs of inflammation were determined in the form of early contrast and/or T2 signal intensity enhancement was 7.25±0.36 segments, and the number of segments with fibrotic myocardial damage was 5.81±0.32 on average. After 6 months, inflammatory changes were detected only in 2.20±0.17 LV segments, while the volume of fibrotic LV damage did not significantly change compared to the initial examination. When analyzing echocardiography data after 6 months of observation, a significant decrease in the LV end-diastolic volume index by 15.6% (p<0.05) and an increase in LV EF by 16.7% (p<0.05) were found. Also, after 6 months of observation, a significant decrease in the content of systemic inflammation markers was detected: the level of ferritin decreased by 41.5% (p<0.01), C-reactive protein – by 34.2% (p<0.01), the content of interleukin-6 and tumor necrosis factor α decreased by 93.8% and 33.3%, respectively (p<0.01), and the content of troponin I decreased 3 times compared to the baseline level before the appointment of azathioprine. According to the results of the 6-minute test, before the appointment of azathioprine, patients with FC III HF predominated, only a third had FC II, and 20% – FC IV. After 6 months of treatment, more than half of the studied patients had FC II HF, every fourth – FC I, and FC IV was not diagnosed in any patient.Conclusions. In patients with severe myocarditis, combined immunosuppressive therapy with azathioprine and glucocorticoids for 6 months was accompanied by a decrease in dilatation and improving the contractility of the left ventricle, improving the functional class of heart failure, reducing the number of myocardial segments affected by inflammatory changes as well as reducing the content of systemic inflammation markers.
- Open Access
- 27 December 2024
- Published by Chetverta Khvylia in Ukrainian Journal of Cardiology
- Vol. 31 (6) , 7-13
Results of one-year follow-up of patients with severe myocarditis associated with COVID-19 on glucocorticoid therapy
The aim of the study – to investigate the effectiveness and safety of glucocorticoid therapy in patients with severe myocarditis associated with COVID-19.Materials and methods. The results are based on data obtained from 72 patients with severe acute myocarditis (AM) and heart failure (HF) with reduced left ventricular ejection fraction (LVEF ≤ 40 %). Patients were divided into two groups: the group 1 included 34 patients with AM, who had a documented history of coronavirus disease ≤ 3 months before the onset of clinical symptoms of AM; the group 2 consisted of 38 patients with AM, who had no history of coronavirus disease. All patients received optimal therapy for heart failure during all period of follow-up and immunosuppressive therapy with glucocorticoids (GKs) within first 6 months from the onset of AM. Patients underwent for echocardiography with speckle tracking and cardiac magnetic resonance (CMR). The studies were conducted three times: in the first month from the onset of clinical symptoms of myocarditis, after 6 months, and after 12 months of observation.Results and discussion. After 6 months of follow-up, improvements in the structural and functional state of the heart were observed in both groups, with group 1 showing greater increases in LVEF and LGSS by 13.1 % and 22.2 %, respectively (p<0.05). Additionally, group 1 exhibited a reduction in the number of LV segments affected by inflammatory changes and the total number of damaged segments by 28.4 % and 18.3 %, respectively, compared to group 2 (p<0.05–0.001). After 12 months results of CMR demonstrated significantly less myocardial damage in group 1 compared to group 2: the total number of LV segments affected by inflammation and/or fibrosis was 39.0 % lower (p<0.001). The most common complications of GKs therapy after 6 months were obesity (13.88 %) and leukocytosis (12.50 %), while hypokalemia occurred in 6.94 % of cases. Complications such as arterial hypertension, hyperglycemia, functional hypercortisolism, and myalgia were recorded in 4.16 % of cases. After 12 months, a significant reduction or complete resolution of GC-associated complications was observed in most patients: only 7 cases (9.72 %) of pathology associated with GC therapy were recorded.Conclusions. In patients with acute severe myocarditis with a history of coronavirus disease, glucocorticoid therapy demonstrated greater efficacy in improving the structural and functional state of the heart after 6 months of follow-up compared to patients without a history of COVID-19. The use of glucocorticoids in patients with severe myocarditis was associated with the development of complications in more than a half of patients within the first 6 months of follow-up, while after 12 months, there was a significant reduction in their frequency or their complete regression. During the 12-month observation period, none of the patients developed diseases or pathological conditions associated with glucocorticoid use that required inpatient treatment.
- 27 December 2024
- Published by Chetverta Khvylia in Ukrainian Journal of Cardiology
- Vol. 31 (6) , 7-13
Open AccessResults of one-year follow-up of patients with severe myocarditis associated with COVID-19 on glucocorticoid therapy
The aim of the study – to investigate the effectiveness and safety of glucocorticoid therapy in patients with severe myocarditis associated with COVID-19.Materials and methods. The results are based on data obtained from 72 patients with severe acute myocarditis (AM) and heart failure (HF) with reduced left ventricular ejection fraction (LVEF ≤ 40 %). Patients were divided into two groups: the group 1 included 34 patients with AM, who had a documented history of coronavirus disease ≤ 3 months before the onset of clinical symptoms of AM; the group 2 consisted of 38 patients with AM, who had no history of coronavirus disease. All patients received optimal therapy for heart failure during all period of follow-up and immunosuppressive therapy with glucocorticoids (GKs) within first 6 months from the onset of AM. Patients underwent for echocardiography with speckle tracking and cardiac magnetic resonance (CMR). The studies were conducted three times: in the first month from the onset of clinical symptoms of myocarditis, after 6 months, and after 12 months of observation.Results and discussion. After 6 months of follow-up, improvements in the structural and functional state of the heart were observed in both groups, with group 1 showing greater increases in LVEF and LGSS by 13.1 % and 22.2 %, respectively (p<0.05). Additionally, group 1 exhibited a reduction in the number of LV segments affected by inflammatory changes and the total number of damaged segments by 28.4 % and 18.3 %, respectively, compared to group 2 (p<0.05–0.001). After 12 months results of CMR demonstrated significantly less myocardial damage in group 1 compared to group 2: the total number of LV segments affected by inflammation and/or fibrosis was 39.0 % lower (p<0.001). The most common complications of GKs therapy after 6 months were obesity (13.88 %) and leukocytosis (12.50 %), while hypokalemia occurred in 6.94 % of cases. Complications such as arterial hypertension, hyperglycemia, functional hypercortisolism, and myalgia were recorded in 4.16 % of cases. After 12 months, a significant reduction or complete resolution of GC-associated complications was observed in most patients: only 7 cases (9.72 %) of pathology associated with GC therapy were recorded.Conclusions. In patients with acute severe myocarditis with a history of coronavirus disease, glucocorticoid therapy demonstrated greater efficacy in improving the structural and functional state of the heart after 6 months of follow-up compared to patients without a history of COVID-19. The use of glucocorticoids in patients with severe myocarditis was associated with the development of complications in more than a half of patients within the first 6 months of follow-up, while after 12 months, there was a significant reduction in their frequency or their complete regression. During the 12-month observation period, none of the patients developed diseases or pathological conditions associated with glucocorticoid use that required inpatient treatment.
- Open Access
- 31 August 2024
- Published by Chetverta Khvylia in Ukrainian Journal of Cardiology
- Vol. 31 (4) , 53−60
Визначення предикторів стійких порушень серцевого ритму у військовослужбовців із тяжким перебігом міокардиту
The aim – to study heart rhythm and conduction disturbances in different localization and distribution of myocardial lesions in combatants with severe myocarditis based on the results of a 6-month follow-up.Materials and methods. 46 male military personnel with a severe course of acute myocarditis (AM) with a reduced ejection fraction (EF) of the left ventricle (LV) (≤ 40 %) with an average age of (35,1±2,4) years were examined. Examinations were carried out in the 1st month after the onset of symptoms of myocarditis and after 6 months of observation. The diagnosis of myocarditis and the severe course of the disease were established on the basis of the Recommendations for the diagnosis and treatment of myocarditis of the All-Ukrainian Association of Cardiologists of Ukraine. All patients underwent for 24-hour ECG monitoring with analysis of the frequency and spectrum of rhythm and conduction disturbances and cardiac magnetic resonance (CMR) imaging with contrast analysis of the topography of the lesion and counting the number of LV segments affected by inflammatory changes and LV segments with the presence of late gadolinium enhancement (LGE).Results and discussion. When comparing the results of heart MRI with the data of daily ECG monitoring, a clear association of the presence of frequent ventricular extrasystoles (VE) and paroxysms of non-sustained ventricular tachycardia (NSVT) with the localization of LGE in the interventricular septum (IS) was established – among patients with LGE lesions at the onset of AM more than in a third (37.0 %) had frequent VE, and NSVT paroxysms, which increase the risk of developing life-threatening ventricular arrhythmias, were detected in 25,9 % of cases. After 6 months of observation in the presence of LGE in the IS, the frequency of detection of frequent VE and NSVT paroxysms was also significantly higher compared to other localization of the lesion and amounted to 20,0 and 13,3 %, respectively. With the help of correlation analysis, an associative relationship was revealed between the presence of LGE in the IS and the presence of frequent VE and NSVT paroxysms in the debut of myocarditis – r=0.73 (р<0.01) and r=0.66 (р<0,01) respectively, and also after 6 months of observation – r=0.65 (р<0.01) and r=0.59 (р<0.05), respectively. According to the results of the multivariate regression analysis, predictors of frequent VE persistence after 6 months were: LVEF ≤30 %; LV end-diastolic volume index ≥105 ml/m2; presence of inflammatory changes in ≥5.0 LV segments; presence of LGE in ≥4.0 LV segments and its presence in the IS, determined in the 1st month from the onset of the disease. The predictors NSVT paroxysms persistence after 6 months were the same factors with the exception of LV EF, and, according to the value of the β coefficient (β=1.302; p<0.001), the most significant contribution was the presence of LGE in the IS.Conclusions. In combatants with severe myocarditis, the presence of late gadolinium enhancement in the interventricular septum is an additional risk factor for the persistence of frequent ventricular extrasystoles and paroxysms of non-sustained ventricular tachycardia during 6 months, while the presence of late gadolinium enhancement in the posterior and lateral walls of the left ventricle has no reliable relationship with the presence of rhythm and conduction disorders. On the basis of multivariate regression analysis, predictors of frequent ventricular extrasystoles and paroxysms of non-sustained ventricular tachycardia persistence were established in combatants with myocarditis.
- 31 August 2024
- Published by Chetverta Khvylia in Ukrainian Journal of Cardiology
- Vol. 31 (4) , 53−60
Open AccessВизначення предикторів стійких порушень серцевого ритму у військовослужбовців із тяжким перебігом міокардиту
The aim – to study heart rhythm and conduction disturbances in different localization and distribution of myocardial lesions in combatants with severe myocarditis based on the results of a 6-month follow-up.Materials and methods. 46 male military personnel with a severe course of acute myocarditis (AM) with a reduced ejection fraction (EF) of the left ventricle (LV) (≤ 40 %) with an average age of (35,1±2,4) years were examined. Examinations were carried out in the 1st month after the onset of symptoms of myocarditis and after 6 months of observation. The diagnosis of myocarditis and the severe course of the disease were established on the basis of the Recommendations for the diagnosis and treatment of myocarditis of the All-Ukrainian Association of Cardiologists of Ukraine. All patients underwent for 24-hour ECG monitoring with analysis of the frequency and spectrum of rhythm and conduction disturbances and cardiac magnetic resonance (CMR) imaging with contrast analysis of the topography of the lesion and counting the number of LV segments affected by inflammatory changes and LV segments with the presence of late gadolinium enhancement (LGE).Results and discussion. When comparing the results of heart MRI with the data of daily ECG monitoring, a clear association of the presence of frequent ventricular extrasystoles (VE) and paroxysms of non-sustained ventricular tachycardia (NSVT) with the localization of LGE in the interventricular septum (IS) was established – among patients with LGE lesions at the onset of AM more than in a third (37.0 %) had frequent VE, and NSVT paroxysms, which increase the risk of developing life-threatening ventricular arrhythmias, were detected in 25,9 % of cases. After 6 months of observation in the presence of LGE in the IS, the frequency of detection of frequent VE and NSVT paroxysms was also significantly higher compared to other localization of the lesion and amounted to 20,0 and 13,3 %, respectively. With the help of correlation analysis, an associative relationship was revealed between the presence of LGE in the IS and the presence of frequent VE and NSVT paroxysms in the debut of myocarditis – r=0.73 (р<0.01) and r=0.66 (р<0,01) respectively, and also after 6 months of observation – r=0.65 (р<0.01) and r=0.59 (р<0.05), respectively. According to the results of the multivariate regression analysis, predictors of frequent VE persistence after 6 months were: LVEF ≤30 %; LV end-diastolic volume index ≥105 ml/m2; presence of inflammatory changes in ≥5.0 LV segments; presence of LGE in ≥4.0 LV segments and its presence in the IS, determined in the 1st month from the onset of the disease. The predictors NSVT paroxysms persistence after 6 months were the same factors with the exception of LV EF, and, according to the value of the β coefficient (β=1.302; p<0.001), the most significant contribution was the presence of LGE in the IS.Conclusions. In combatants with severe myocarditis, the presence of late gadolinium enhancement in the interventricular septum is an additional risk factor for the persistence of frequent ventricular extrasystoles and paroxysms of non-sustained ventricular tachycardia during 6 months, while the presence of late gadolinium enhancement in the posterior and lateral walls of the left ventricle has no reliable relationship with the presence of rhythm and conduction disorders. On the basis of multivariate regression analysis, predictors of frequent ventricular extrasystoles and paroxysms of non-sustained ventricular tachycardia persistence were established in combatants with myocarditis.
- Open Access
- 1 May 2024
- Published by Chetverta Khvylia in Ukrainian Journal of Cardiology
- Vol. 31 (2) , 22-40
Сhoice of RAAS blocker in the treatment of heart failure in acute myocarditis
The aim – to evaluate the effectiveness of sacubitril/valsartan and enalapril in heart failure treatment in patients with acute severe myocarditis with reduced left ventricular ejection fraction based on dynamic analysis of the heart structural and functional changes.Materials and methods. The study is based on the results of examinations of 90 patients with a severe course of acute myocarditis (AM) with reduced ejection fraction (EF) of the left ventricle (LV) – ≤40 %. The patients were divided into two groups: the 1st group included 48 patients who were treated with an angiotensin-converting enzyme (ACE) inhibitor – enalapril as part of heart failure (HF) therapy; the 2nd group included 42 patients with AM who received the sacubitril/valsartan combination instead of enalapril in the complex therapy of HF. All patients underwent a 6-minute walk test, echocardiography (EchoCG) with the speckle-tracking method, and cardiac magnetic resonance imaging (CMR). Examinations were carried out three times: in the 1st month from the onset of AM symptoms before the appointment of drug therapy, after 6 and 12 months of observation. Part of the patients from the 1st group, namely 25 patients (52.1 %) in whom the use of ACE inhibitors proved to be ineffective after six months, was transferred to the combination of sacubitril/valsartan (group 1A).Results and discussion. After six months of treatment, compared to the 1st group, the patients of the 2nd group were distinguished by better indicators of the structural and functional state of the heart, which characterise the contractility and volume of the LV – the values of LV EF and LV longitudinal global systolic strain (LGSS) were higher by 13,7 and 26.2 % respectively, LV end-diastolic volume index (EDVi) was 13.2% lower, as well as a 21.7 % lower number of LV segments in which delayed contrast was detected on cardiac MRI. After six months of taking the sacubitril/valsartan combination in 1A group patients, an improvement in the structural and functional state of the heart was also achieved: the values of LVEF and LGSS increased by 19.2 % and 27.9 %, respectively, and LV EDVi decreased by 19.0 %; the number of LV segments in which delayed enhancement was determined on cardiac MRI decreased by 30.7 %. With the help of regression analysis, it was established the presence of a set of factors that determine the priority of prescribing the sacubitril/valsartan combination as initial therapy in patients with severe myocarditis: presence of reduced LVEF – ≤40 %; pronounced decrease in longitudinal and circular global LV strain – ≤8.5 and ≤9.0 %, respectively; pronounced dilatation of the LV – EDVi ≥102 ml/m2; presence of III or higher HF functional class; presence of delayed enhancement in ≥ 5,0 LV segments according to cardiac MRI data.Conclusions. In patients with a severe course of myocarditis, the sacubitril/valsartan combination prescribed as initial therapy showed higher effectiveness compared to ACE inhibitors in terms of improving contractility and reducing LV dilatation, as well as improving the functional class of heart failure. A complex of factors has been established that prove the expediency of prescribing the sacubitril/valsartan combination as initial therapy for heart failure in patients with acute myocarditis.
- 1 May 2024
- Published by Chetverta Khvylia in Ukrainian Journal of Cardiology
- Vol. 31 (2) , 22-40
Open AccessСhoice of RAAS blocker in the treatment of heart failure in acute myocarditis
The aim – to evaluate the effectiveness of sacubitril/valsartan and enalapril in heart failure treatment in patients with acute severe myocarditis with reduced left ventricular ejection fraction based on dynamic analysis of the heart structural and functional changes.Materials and methods. The study is based on the results of examinations of 90 patients with a severe course of acute myocarditis (AM) with reduced ejection fraction (EF) of the left ventricle (LV) – ≤40 %. The patients were divided into two groups: the 1st group included 48 patients who were treated with an angiotensin-converting enzyme (ACE) inhibitor – enalapril as part of heart failure (HF) therapy; the 2nd group included 42 patients with AM who received the sacubitril/valsartan combination instead of enalapril in the complex therapy of HF. All patients underwent a 6-minute walk test, echocardiography (EchoCG) with the speckle-tracking method, and cardiac magnetic resonance imaging (CMR). Examinations were carried out three times: in the 1st month from the onset of AM symptoms before the appointment of drug therapy, after 6 and 12 months of observation. Part of the patients from the 1st group, namely 25 patients (52.1 %) in whom the use of ACE inhibitors proved to be ineffective after six months, was transferred to the combination of sacubitril/valsartan (group 1A).Results and discussion. After six months of treatment, compared to the 1st group, the patients of the 2nd group were distinguished by better indicators of the structural and functional state of the heart, which characterise the contractility and volume of the LV – the values of LV EF and LV longitudinal global systolic strain (LGSS) were higher by 13,7 and 26.2 % respectively, LV end-diastolic volume index (EDVi) was 13.2% lower, as well as a 21.7 % lower number of LV segments in which delayed contrast was detected on cardiac MRI. After six months of taking the sacubitril/valsartan combination in 1A group patients, an improvement in the structural and functional state of the heart was also achieved: the values of LVEF and LGSS increased by 19.2 % and 27.9 %, respectively, and LV EDVi decreased by 19.0 %; the number of LV segments in which delayed enhancement was determined on cardiac MRI decreased by 30.7 %. With the help of regression analysis, it was established the presence of a set of factors that determine the priority of prescribing the sacubitril/valsartan combination as initial therapy in patients with severe myocarditis: presence of reduced LVEF – ≤40 %; pronounced decrease in longitudinal and circular global LV strain – ≤8.5 and ≤9.0 %, respectively; pronounced dilatation of the LV – EDVi ≥102 ml/m2; presence of III or higher HF functional class; presence of delayed enhancement in ≥ 5,0 LV segments according to cardiac MRI data.Conclusions. In patients with a severe course of myocarditis, the sacubitril/valsartan combination prescribed as initial therapy showed higher effectiveness compared to ACE inhibitors in terms of improving contractility and reducing LV dilatation, as well as improving the functional class of heart failure. A complex of factors has been established that prove the expediency of prescribing the sacubitril/valsartan combination as initial therapy for heart failure in patients with acute myocarditis.
- Open Access
- 1 April 2024
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 29 (1) , 59-66
Dynamics of heart rhythm disorders in combatants with acute myocarditis during a 6-month follow-up
The main factors of an unfavorable prognosis, are life-threatening heart rhythm disorders which determine the severity of the clinical course of myocarditis, in addition to impaired contractility and dilatation of the left ventricle (LV). The aim of the study was to assess the frequency and nature of arrhythmias and establish predictors of their long-term persistence, assess the severity of anxiety and depression, changes in heart rate variability in combatants on the background of changes in the structural and functional state of the left ventricle during a 6-month follow-up. The study included 52 male servicemen (combatants) with acute myocarditis (AM) with an average age of 33.4±2.5 years. All patients were assessed by Questionnaire according to the Hospital Anxiety and Depression Scale (HADS) and underwent 24 hour ECG monitoring, transthoracic echocardiography and cardiac magnetic resonance (CMR) with late enhancement using gadovist. At the onset of AM frequent supraventricular (30.7% of cases) and frequent ventricular (42.3% of cases) extrasystolic arrhythmia, as well as paroxysms of non-sustained ventricular tachycardia (26.9% of cases) on the background of heart rhythm variability disorders were recorded. After 6 months, there was an improvement in the structural and functional state of the heart, which was characterized by a decrease in dilatation and an improvement of LV systolic function, a decrease in the volume of the inflammatory lesion and the total number of affected LV segments revealed on cardiac MRI, which was associated with a decrease in the number of ventricular rhythm disorders and reduction of clinical manifestations of anxiety according to the HADS scale. The obtained data indicate that the persistence of supraventricular rhythm disorders is associated with the long-term presence of anxiety and low values of standard deviation of RR intervals (SDNN) and root mean square of successive differences between normal heartbeats (RMSSD). Also predictors of persistence of non-sustained ventricular tachycardia paroxysms were established – SDNN value ≤80.0 ms, LV end-diastolic volume index ≥95 ml/m2, total number of affected LV segments ≥6 segments, presence of delayed contrasting in ≥3 LV segments, presence of ≥12 points on the HADS scale and predictors of atrial fibrillation – SDNN value ≤80.0 ms, RMSSD value ≤12.0 ms, total number of affected segments of LV≥6 seg. and ≥12 points on the HADS anxiety scale, determined at the onset of AM.
- 1 April 2024
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 29 (1) , 59-66
Open AccessDynamics of heart rhythm disorders in combatants with acute myocarditis during a 6-month follow-up
The main factors of an unfavorable prognosis, are life-threatening heart rhythm disorders which determine the severity of the clinical course of myocarditis, in addition to impaired contractility and dilatation of the left ventricle (LV). The aim of the study was to assess the frequency and nature of arrhythmias and establish predictors of their long-term persistence, assess the severity of anxiety and depression, changes in heart rate variability in combatants on the background of changes in the structural and functional state of the left ventricle during a 6-month follow-up. The study included 52 male servicemen (combatants) with acute myocarditis (AM) with an average age of 33.4±2.5 years. All patients were assessed by Questionnaire according to the Hospital Anxiety and Depression Scale (HADS) and underwent 24 hour ECG monitoring, transthoracic echocardiography and cardiac magnetic resonance (CMR) with late enhancement using gadovist. At the onset of AM frequent supraventricular (30.7% of cases) and frequent ventricular (42.3% of cases) extrasystolic arrhythmia, as well as paroxysms of non-sustained ventricular tachycardia (26.9% of cases) on the background of heart rhythm variability disorders were recorded. After 6 months, there was an improvement in the structural and functional state of the heart, which was characterized by a decrease in dilatation and an improvement of LV systolic function, a decrease in the volume of the inflammatory lesion and the total number of affected LV segments revealed on cardiac MRI, which was associated with a decrease in the number of ventricular rhythm disorders and reduction of clinical manifestations of anxiety according to the HADS scale. The obtained data indicate that the persistence of supraventricular rhythm disorders is associated with the long-term presence of anxiety and low values of standard deviation of RR intervals (SDNN) and root mean square of successive differences between normal heartbeats (RMSSD). Also predictors of persistence of non-sustained ventricular tachycardia paroxysms were established – SDNN value ≤80.0 ms, LV end-diastolic volume index ≥95 ml/m2, total number of affected LV segments ≥6 segments, presence of delayed contrasting in ≥3 LV segments, presence of ≥12 points on the HADS scale and predictors of atrial fibrillation – SDNN value ≤80.0 ms, RMSSD value ≤12.0 ms, total number of affected segments of LV≥6 seg. and ≥12 points on the HADS anxiety scale, determined at the onset of AM.
- Open Access
- 27 December 2023
- Published by Chetverta Khvylia in Ukrainian Journal of Cardiology
- Vol. 30 (5-6) , 51-57
Роль спекл-трекінг ехокардіографії в оцінці геометрії скорочення серця у військовослужбовців із гострим міокардитом
The aim – to evaluate the geometry of heart contraction based on speckle-tracking echocardiography data in combatants with acute myocarditis with reduced and mildly reduced left ventricular ejection fraction.Materials and methods. 53 male combatants with acute myocarditis (AM) were examined, who were divided into 2 groups: 1st group – 30 patients with a reduced ejection fraction (EF) of the left ventricle (LV) ≤ 40 %; 2nd group – 23 patients with mildly reduced LVEF 41–49 %. The diagnosis of AM was established on the basis of the recommendations for the diagnosis and treatment of myocarditis of the All-Ukrainian Association of Cardiologists of Ukraine. All patients underwent echocardiography (EchoCG) with speckle tracking (ST) and cardiac magnetic resonance (CMR) imaging with contrast.Results and discussion. Patients of the 1st group, compared to the 2nd, were characterized by more pronounced manifestations of dilatation and more significant violation of the LV contractile function, which was evidenced by a 13.6 % higher value of the LV end-diastolic volume and a 25.4 % smaller value of the LVEF. When evaluating ST echocardiographic indicators, the value of the longitudinal global systolic strain (LGSS) of the LV in the 1st group was 43.1 % lower, its velocity by 19.2 %, and the circular systolic deformation by 20.9 % in comparison with those in the 2nd group. In addition, in the 1st group, in comparison with the 2nd, the value of the indicator of systolic deformation of the left atrium (SDLA) was almost twice smaller. According to the results of CMR, in the 1st group compared to the 2nd, a larger number of segments with the presence of delayed enhancement was determined, which indicated a larger volume of fibrotic/necrotic lesions of the LV. According to the results of the correlation analysis in the 1st group, strong reverse relationships were established between the presence of delayed contrast in ≥ 4 segments of the LV and LGSS (r=–0.76; p<0.01), its speed and (r=–0.71; p<0.02) and SDLA (r=–0.52; p<0.05).Conclusions. Patients with acute myocarditis with a reduced left ventricular ejection fraction compared to patients with a mildly reduced ejection fraction were characterized by a greater violation of the geometry of the contraction of the left ventricle, which was observed on the background of a larger volume of fibrotic/necrotic lesions. With the help of correlation analysis, in combatants with acute myocarditis, a relationship was established between the presence of delayed enhancement in ≥ 4 segments of the left ventricle and a decrease in indicators of longitudinal systolic deformation and its speed, as well as an indicator of systolic deformation of the left atrium.
- 27 December 2023
- Published by Chetverta Khvylia in Ukrainian Journal of Cardiology
- Vol. 30 (5-6) , 51-57
Open AccessРоль спекл-трекінг ехокардіографії в оцінці геометрії скорочення серця у військовослужбовців із гострим міокардитом
The aim – to evaluate the geometry of heart contraction based on speckle-tracking echocardiography data in combatants with acute myocarditis with reduced and mildly reduced left ventricular ejection fraction.Materials and methods. 53 male combatants with acute myocarditis (AM) were examined, who were divided into 2 groups: 1st group – 30 patients with a reduced ejection fraction (EF) of the left ventricle (LV) ≤ 40 %; 2nd group – 23 patients with mildly reduced LVEF 41–49 %. The diagnosis of AM was established on the basis of the recommendations for the diagnosis and treatment of myocarditis of the All-Ukrainian Association of Cardiologists of Ukraine. All patients underwent echocardiography (EchoCG) with speckle tracking (ST) and cardiac magnetic resonance (CMR) imaging with contrast.Results and discussion. Patients of the 1st group, compared to the 2nd, were characterized by more pronounced manifestations of dilatation and more significant violation of the LV contractile function, which was evidenced by a 13.6 % higher value of the LV end-diastolic volume and a 25.4 % smaller value of the LVEF. When evaluating ST echocardiographic indicators, the value of the longitudinal global systolic strain (LGSS) of the LV in the 1st group was 43.1 % lower, its velocity by 19.2 %, and the circular systolic deformation by 20.9 % in comparison with those in the 2nd group. In addition, in the 1st group, in comparison with the 2nd, the value of the indicator of systolic deformation of the left atrium (SDLA) was almost twice smaller. According to the results of CMR, in the 1st group compared to the 2nd, a larger number of segments with the presence of delayed enhancement was determined, which indicated a larger volume of fibrotic/necrotic lesions of the LV. According to the results of the correlation analysis in the 1st group, strong reverse relationships were established between the presence of delayed contrast in ≥ 4 segments of the LV and LGSS (r=–0.76; p<0.01), its speed and (r=–0.71; p<0.02) and SDLA (r=–0.52; p<0.05).Conclusions. Patients with acute myocarditis with a reduced left ventricular ejection fraction compared to patients with a mildly reduced ejection fraction were characterized by a greater violation of the geometry of the contraction of the left ventricle, which was observed on the background of a larger volume of fibrotic/necrotic lesions. With the help of correlation analysis, in combatants with acute myocarditis, a relationship was established between the presence of delayed enhancement in ≥ 4 segments of the left ventricle and a decrease in indicators of longitudinal systolic deformation and its speed, as well as an indicator of systolic deformation of the left atrium.
- Open Access
- 30 November 2022
- Published by Institute of Cell Therapy in Cell and Organ Transplantology
- Vol. 10 (2)
Stem cell therapy of myocarditis and cardiomyopathies: a promising strategy
The literature review is devoted to the analysis of modern data on the effectiveness of stem cell transplantation in patients with non-coronary heart diseases: myocarditis, dilated cardiomyopathy, and systemic amyloidosis with heart damage. The results of experimental studies on laboratory animals and clinical trials concerning the use of various types of stem cells, their mechanisms of action and prospects for application in non-coronary heart diseases are presented. Emphasis is placed on the need for further randomized multicenter clinical trials, especially in patients with inflammatory myocardial injury, involving a large number of patients.
- 30 November 2022
- Published by Institute of Cell Therapy in Cell and Organ Transplantology
- Vol. 10 (2)
Open AccessStem cell therapy of myocarditis and cardiomyopathies: a promising strategy
The literature review is devoted to the analysis of modern data on the effectiveness of stem cell transplantation in patients with non-coronary heart diseases: myocarditis, dilated cardiomyopathy, and systemic amyloidosis with heart damage. The results of experimental studies on laboratory animals and clinical trials concerning the use of various types of stem cells, their mechanisms of action and prospects for application in non-coronary heart diseases are presented. Emphasis is placed on the need for further randomized multicenter clinical trials, especially in patients with inflammatory myocardial injury, involving a large number of patients.